Related Experiment Video
Updated: May 6, 2026
10:45
The Mouse Stroke Unit Protocol with Standardized Neurological Scoring for Translational Mouse Stroke Studies
Published on: February 7, 2025
542
Stroke-Related Sarcopenia: Pathophysiology and Diagnostic Tools.
Jinmann Chon1, Yunsoo Soh1, Ga Yang Shim1
1Department of Physical and Rehabilitation Medicine, Kyung Hee University Hospital, Seoul, Korea.
Brain & Neurorehabilitation
|December 9, 2024
Summary
Sarcopenia, the loss of muscle mass and strength, can worsen outcomes for stroke survivors. New diagnostic standards are needed to better assess this condition in stroke patients.
Area of Science:
- Gerontology
- Neurology
- Muscle physiology
Background:
- Sarcopenia is defined as progressive skeletal muscle mass loss and strength decline.
- It can be primary or secondary, with stroke patients being at risk for secondary sarcopenia.
- Sarcopenia negatively impacts functional recovery post-stroke.
Purpose of the Study:
- To highlight the link between stroke and sarcopenia.
- To discuss the pathophysiology of sarcopenia in stroke patients.
- To emphasize the need for adapted diagnostic criteria for sarcopenia in stroke survivors.
Main Methods:
- Review of existing literature on sarcopenia and stroke.
- Analysis of pathophysiological mechanisms connecting stroke and muscle loss.
- Evaluation of current diagnostic tools for sarcopenia.
Main Results:
- Stroke is associated with sarcopenia through mechanisms like nutritional deficiency, disuse atrophy, denervation, and metabolic changes.
- Existing sarcopenia diagnostic tools may not adequately capture the functional deficits in stroke patients.
- There is a clear need for specialized diagnostic criteria.
Conclusions:
- Sarcopenia poses a significant challenge to stroke patient recovery.
- Current diagnostic approaches for sarcopenia are insufficient for the stroke population.
- Developing stroke-specific sarcopenia diagnostic standards is crucial for accurate assessment and management.
